| # | Side effect | Count |
|---|---|---|
| 0 | INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 219 |
| 1 | PYREXIA | 179 |
| 2 | OFF LABEL USE | 153 |
| 3 | DYSPNOEA | 141 |
| 4 | MALAISE | 105 |
| 5 | FATIGUE | 100 |
| 6 | PNEUMONIA | 100 |
| 7 | FALL | 95 |
| 8 | DRUG SPECIFIC ANTIBODY PRESENT | 89 |
| 9 | URTICARIA | 87 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | DRUG ADMINISTERED TO FOETUS | 1 | 0.5000 |
| 1 | ALDOLASE DECREASED | 1 | 0.5000 |
| 2 | URINARY HEXOSE TETRASACCHARIDE INCREASED | 18 | 0.4615 |
| 3 | GLYCOGEN STORAGE DISEASE TYPE II | 16 | 0.1524 |
| 4 | COMPLEMENT FIXATION TEST POSITIVE | 1 | 0.1111 |
| 5 | WINGED SCAPULA | 4 | 0.1053 |
| 6 | NEUTRALISING ANTIBODIES NEGATIVE | 4 | 0.1026 |
| 7 | BLOOD IMMUNOGLOBULIN G | 4 | 0.1000 |
| 8 | GENDER REASSIGNMENT THERAPY | 1 | 0.0909 |
| 9 | DRUG SPECIFIC ANTIBODY ABSENT | 18 | 0.0882 |